TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01398358

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parents of Preschoolers Series
Description: The POPS-Parent intervention consists of eight 60-90 minute lessons about preventing childhood obesity followed by four 10-minute reinforcing telephone contacts. Each lesson includes opportunities for parents to develop and practice skills, and a discussion of strategies to overcome challenges and problem-solving techniques, with an emphasis on building knowledge and self-efficacy.~The POPS-Child Intervention uses children's stories with embedded healthy nutrition themes. Five lessons (6 books) are delivered over 12 weeks. Activities include classroom cooking experiences, games/activities associated with the story's nutrition themes, and goal setting. Family Links and Parent Pages are sent home to reinforce content from school to home.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parents of Preschoolers Series
Description: The POPS-Parent intervention consists of eight 60-90 minute lessons about preventing childhood obesity followed by four 10-minute reinforcing telephone contacts. Each lesson includes opportunities for parents to develop and practice skills, and a discussion of strategies to overcome challenges and problem-solving techniques, with an emphasis on building knowledge and self-efficacy.~The POPS-Child Intervention uses children's stories with embedded healthy nutrition themes. Five lessons (6 books) are delivered over 12 weeks. Activities include classroom cooking experiences, games/activities associated with the story's nutrition themes, and goal setting. Family Links and Parent Pages are sent home to reinforce content from school to home.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Incredible Years Series
Description: The Parent component (BASIC) is a group-based program (12-14 weeks, 2 hours/week) focused on enhancing parenting skills such as using effective praise, incentives, and limit-setting, and handling misbehavior. Parents complete homework activities that will be reviewed in group sessions and receive follow-up reinforcement phone calls.~For the Child component (Dinosaur School), 60, 15-20 minute lessons are delivered during Circle Time in Head Start classrooms followed by small group activities. The curriculum focuses on teaching self-regulation skills, problem-solving strategies, and prosocial behaviors.~Teachers are trained in classroom management strategies.
Study: NCT00507988

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Complex Problem Solving Training
Description: 10 sessions of 45 minutes complex problem solving training over 3 weeks (including 30 minutes of computerized planning and problem-solving training with Plan-A-Day and 15 minutes group session for transfer to everyday situations)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Basic Cognitive Training
Description: 10 sessions over 3 weeks of 45 min basic cognitive training (including 45 min computerized training of attention, processing speed, memory)
Study: NCT01118663

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetadote EF (Ethylenediaminetetraacetic Acid (EDTA) - Free)
Description: Acetadote EF (Ethylenediaminetetraacetic Acid (EDTA) - Free) {new formulation} 200 mg/kg in 1000 ml diluent over 4 hours; then 100 mg/kg in 1000 ml diluent over 16 hours
Study: NCT04561947

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tunnel technique
Description: After local anesthesia, the exposed root surfaces were mechanically treated with curettes. A tunnelling knives were used to prepare a split-thickness flap and create a continuous tunnel in the buccal soft tissues, following the intrasulcular incision with a #69 microblade. Split-thickness flap preparation was performed to beyond the mucogingival junction with supraperiosteal dissection by placing the tunneling knives to the soft tissue. This process was repeated by entering through the sulcus of each tooth. After the elevation of the flap, a papilla elevator placed under the flap was entered through the sulcus to mobilize the papilla, the periosteum at the base of the papilla was cut, and the full-thickness flap was elevated.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Tunnel technique
Description: After local anesthesia, the exposed root surfaces were mechanically treated with curettes. A tunnelling knives were used to prepare a split-thickness flap and create a continuous tunnel in the buccal soft tissues, following the intrasulcular incision with a #69 microblade. Split-thickness flap preparation was performed to beyond the mucogingival junction with supraperiosteal dissection by placing the tunneling knives to the soft tissue. This process was repeated by entering through the sulcus of each tooth. After the elevation of the flap, a papilla elevator placed under the flap was entered through the sulcus to mobilize the papilla, the periosteum at the base of the papilla was cut, and the full-thickness flap was elevated.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Connective tissue graft
Description: CTG was harvested using the de-epithelialized connective tissue graft technique. The epithelial tissue on the outer surface of the graft was removed with a 15 blade and a 1-mm-thick graft was obtained.
Study: NCT01118663

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetadote
Description: Acetadote \[old formulation\] 150 mg/kg in 200 mL diluent over 60 minutes; then Acetadote 50 mg/kg in 500 mL diluent over 4 hours; then Acetadote 100 mg/kg in 1000 mL diluent over 16 hours.
Study: NCT01087203

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tanezumab
Description: 20 mg subcutaneous injection every 8 weeks x 2 doses (at Baseline and week 8)

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Placebo to match tanezumab 20 mg subcutaneous injection every 8 weeks x 2 doses (at Baseline and week 8)
Study: NCT02650492

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Immunostimulating Interstitial Laser Thermotherapy
Description: Immunostimulating Interstitial Laser Thermotherpy (imILT) is a specific form of thermotherapy, which, in addition to destroying tumor tissue, has been optimized to cause a tumor specific immunologic response.
Study: NCT02134392

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fecal Microbiota Transplantation
Description: 250 ml of a fecal suspension diluted in saline will be administered via colonoscopy or enema in patients with recurrent c-diff.
Study: NCT02419391

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MVA BN RSV
Description: Liquid frozen suspension of MVA-mBN294B

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MVA BN RSV
Description: Liquid frozen suspension of MVA-mBN294B

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MVA BN RSV
Description: Liquid frozen suspension of MVA-mBN294B

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Tris Buffered Saline, sterile

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Tris Buffered Saline, sterile

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Tris Buffered Saline, sterile
Study: NCT02794506

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propolis
Description: Propolis capsules was taken by the experimental group for 6 months after receiving scaling and root planing (SRP).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules was taken by the control group for 6 months after receiving scaling and root planing (SRP).
Study: NCT01473225

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Calorie information
Description: Nutrition label featuring calorie information will be provided.
Study: NCT04561947

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Concentrated growth factor membrane
Description: Intravenous blood samples were collected in without anticoagulant 10-mL tubes and immediately centrifuged in a CGF centrifuge machine using a program with the following features: 30 ̋ acceleration, 2 min at 2700 rpm, 4 min at 2400 rpm, 4 min at 2700 rpm, 3 min at 3000 rpm, and 36 ̋ deceleration and stop. After centrifugation, four layers were formed in the tube: the serum layer at the top, the second buffy coat layer, the third CGF layer containing GF and unipotent stem cells, and the red blood cell layer at the bottom. The resulting CGF was removed from the tube and separated from the red blood cell layer using microsurgical scissors.
Study: NCT03338439

Intervention type: DEVICE
Intervention: CSII
Description: This retrospective, observational trial will evaluate 104 diabetic patients with prior treatment with MDI initiating CSII therapy compared to 109 diabetic patients continuing MDI.
Study: NCT00412607

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NAVISTAR® THERMOCOOL® Catheter
Description: The primary objective is to provide additional, corroborative safety data for the NAVISTAR THERMOCOOL catheter for the treatment of subjects with sustained, monomorphic VT or incessant VT associated with coronary artery disease
Study: NCT01804868

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: case vignette tutorial
Description: The web tutorial will be composed of 4 case vignettes. A case vignette is a clinical scenario based on clinical practice. It will ask a clinical problem the student will have to answer by reading a research article on a randomized clinical trial. Then he will have to answer questions about this article which are related to the major methodological points of a randomized trial. All these steps are available on a secured website.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: passive web presentation on research regulation
Description: The presentation will be a web-based voice commented video presentation on research regulation. It will allow to preserve a minimal blinding of participants, since the participants will not be informed of the intervention evaluated and will have the opportunity to follow the other intervention after the evaluation.
Study: NCT02902159

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: BWW Online Peer Support
Description: Free access to BWW online peer support and other services offered by them (except live therapy), for 6 months.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NHS Moodzone Online Information
Description: Directed to access to online information from NHS Moodzone
Study: NCT02968615

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dietary Intervention
Description: Participants were instructed to increase both their dietary fiber intake to 35 g/day and protein intake to 0.8 g per kilogram/day of their ideal body weight. Patients in both conditions will receive intensive dietary instruction for 6 weeks, followed by a 6 weeks maintenance phase. Participants received dietary instructions via individual and group sessions led by registered dietitians.
Study: NCT03185884

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: control carbohydrate blend

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental
Description: experimental carbohydrate blend
Study: NCT02165553

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Hibiscus sabdariffa calyces extract as a cold drink

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Hibiscus sabdariffa calyces extract as a cold drink
Study: NCT00653731

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Snoezelen ©
Description: Nursing individual intervention one time a week for 20 minutes

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: structured reminiscence therapy
Description: Individual nursing intervention: one time a week 20 minutes

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 10-minutes activation
Description: Individual nursing intervention: two times a week for 10 minutes

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Unstructured verbal communication
Description: Individual nursing intervention: one time a week for 20 minutes
Study: NCT02693197

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T-817MA
Description: A single oral dose of 448 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T-817MA
Description: A single oral dose of 448 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T-817MA
Description: A single oral dose of 448 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T-817MA
Description: A single oral dose of 448 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T-817MA
Description: A single oral dose of 448 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T-817MA
Description: A single oral dose of 448 mg
Study: NCT04608838

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: JTR-161
Description: JTR-161 (1 or 3 × 10\^8 cells/subject) will be suspended and administered in an intravenously infusion.

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be suspended and administered in an intravenously infusion.
Study: NCT03843099

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Weight Loss + Future Thinking
Description: Participants will receive a 4-week behavioral weight loss intervention based on evidence-based weight loss strategies focused on diet, exercise, and behavioral skills.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral Weight Loss + Healthy Thinking
Description: Participants will receive a 4-week behavioral weight loss intervention based on evidence-based weight loss strategies focused on diet, exercise, and behavioral skills.
Study: NCT00762476

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3804-250A
Description: * topical product~* apply 2 pumps~* apply at least every 4 hours or after hand washing

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 3804-291
Description: * topical~* apply 2 pumps~* apply at least every 4 hours or after hand washing
Study: NCT05443113

Intervention type: DIAGNOSTIC_TEST
Intervention: Genetic analysis
Description: Genetic analysis by geneticists
Study: NCT03878329

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: remote home monitoring
Description: Will use telemedicine to guide behavior changes in outcomes
Study: NCT01645306

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: single intravenous injection
Study: NCT04469608

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: Traditional Chinese medicine clinical daycare
Study: NCT02370407

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: a laparoscopic simulator (Fundamentals of Laparoscopic Surgery (FLS), VT Medical Inc, Waltham, MA)
Description: 10 repetitions of practice on laparoscopic simulator.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mimic da Vinci robotic simulator
Description: 10 repetitions of practice on Mimic da Vinci robotic simulator.
Study: NCT03770923

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rupatadine
Description: Rupatadine 10 mg daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Montelukast
Description: Montelukast 10 mg daily
Study: NCT02563509

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: HIV-specific CD8 cells
Description: Based on HAART, receive HIV-specific CD8 cells transfuion.
Study: NCT03923036

Intervention type: DRUG
Intervention: Antineoplastic Agents
Description: Exposure measurement to any anticancer drug in its therapeutic use for the metastatic colorectal cancer with its posology and duration (the list provided is non-limitative). Exposure to anticancer drugs for another indication than the colorectal cancer will also be collected.
Study: NCT04752436

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supra high intensity interval training
Description: The exercise program will consist of eight 20-second all-out exercise bouts followed by 10 seconds of rest for a total of 4 minutes of total exercise duration. The intensity of exercise is all out. The exercise will be conducted 3 times a week for 8 weeks.
Study: NCT02204371

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pazopanib
Description: Pazopanib is available as 50 mg and 200 mg tablets to be administered orally once daily in the morning at least one hour before or two hours after a meal for 12 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pazopanib
Description: Pazopanib is available as 50 mg and 200 mg tablets to be administered orally once daily in the morning at least one hour before or two hours after a meal for 12 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Pazopanib matching placebo is available as tablets to be administered orally once daily in the morning at least one hour before or two hours after a meal for 12 weeks
Study: NCT04016636

Intervention type: OTHER
Intervention: Standard of Care
Description: Participants in this observational study with confirmed diagnosis of CLL receiving ibrutinib in routine clinical practice settings will be observed approximately for 12 months.
Study: NCT05705713

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: chest computed tomography (CT)
Description: Within the first 12 hours of suspected inhalation lung injury, fiberoptic bronchoscopy was done to confirm the diagnosis. After confirming the diagnosis, an initial chest CT in the first 24 hrs through which the radiologist score (RADS) together with bronchial wall thickening (BWT) was done.

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: chest computed tomography (CT)
Description: Within the first 12 hours of suspected inhalation lung injury, fiberoptic bronchoscopy was done to confirm the diagnosis. After confirming the diagnosis, an initial chest CT in the first 24 hrs through which the radiologist score (RADS) together with bronchial wall thickening (BWT) was done.
Study: NCT00619632

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lactation Consultant
Description: Lactation consultant- primary care based, meets with women pre-natally, in the hospital, and at home up to 6 months post-partum.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Provider Prompt
Description: Prompt in electronic prenatal record will appear 5 times throughout pregnancy re: up to 10 open-ended discussion points for provider to raise

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LC+ Provider Prompt
Description: Participants in this group receive both the LC and Provider Prompt interventions.
Study: NCT03864588

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ropivacaine
Description: For primary TKA, Ropivacaine is used in both arms, either performed intra-operatively by surgeon or post-operatively (ultrasound guided) by anesthesiologist.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Description: For primary TKA, Ropivacaine is used in both arms, either performed intra-operatively by surgeon or post-operatively (ultrasound guided) by anesthesiologist.
Study: NCT01697722

Intervention type: DRUG
Intervention: Extra-fine hydrofluoroalkane-beclometasone dipropionate
Description: Increase in the baseline BDP-equivalent dose of inhaled corticosteroid as HFA-BDP via pMDI or BAI

Intervention type: DRUG
Intervention: ICS / LABA via separate pMDI and / or BAI inhalers
Description: A step-up from baseline ICS therapy via the addition of a separate long-acting beta-agonist with no change in baseline ICS drug or dose
Study: NCT02185612

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Savings program
Description: The intervention is a web-based centralized savings account, which is a secure online account without fees. The account offers eligible savers nominal financial rewards for each deposit they make, as a financial incentive for savings.
Study: NCT01690936

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Almonds 43g/day
Description: 43 grams of almonds were supplemented to the 4 intervention arms but eaten at different times of day (with meals or alone as snacks) for 4 weeks. Control group was asked to avoid all nuts/seeds during the study period

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Almonds 43g/day
Description: 43 grams of almonds were supplemented to the 4 intervention arms but eaten at different times of day (with meals or alone as snacks) for 4 weeks. Control group was asked to avoid all nuts/seeds during the study period

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Almonds 43g/day
Description: 43 grams of almonds were supplemented to the 4 intervention arms but eaten at different times of day (with meals or alone as snacks) for 4 weeks. Control group was asked to avoid all nuts/seeds during the study period

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Almonds 43g/day
Description: 43 grams of almonds were supplemented to the 4 intervention arms but eaten at different times of day (with meals or alone as snacks) for 4 weeks. Control group was asked to avoid all nuts/seeds during the study period
Study: NCT03493126

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Estradiol
Description: 17β-estradiol vaginal cream

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Compounded placebo cream
Study: NCT02737215

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CPAP
Description: patients will receive CPAP therapy with Auto-CPAP
Study: NCT00612326

Intervention type: PROCEDURE
Intervention: MRI and PET scanning procedures
Description: a CT scan, MRI, and C-11 Acetate PET scan. All these scans will be done as an outpatient. After you finish these scans, your doctor will schedule you for surgery to remove your bladder and lymph nodes.
Study: NCT00967642

Intervention type: DRUG
Group type: OTHER
Intervention: Intravenous Insulin
Description: continuous intravenous insulin/24h guided by glycemia (Optium, Abbott) evaluated hourly, targeting values lower than 110 mg/dl
Study: NCT04000321

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Windmill at 30 Minutes
Description: The so-called windmill technique of placenta development for the management of the retained placenta involves the application of a continuous 360-degree umbilical traction force with centripetal rotation in such a way that it runs at the level of the introitus perpendicular to the direction of the birth canal. This rotation around a 360-degree traction plane is repeated slowly and continuously with a motion that resembles the motion of the wings of a windmill until the placenta can be safely delivered.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Windmill at 45 Minutes
Description: The so-called windmill technique of placenta development for the management of the retained placenta involves the application of a continuous 360-degree umbilical traction force with centripetal rotation in such a way that it runs at the level of the introitus perpendicular to the direction of the birth canal. This rotation around a 360-degree traction plane is repeated slowly and continuously with a motion that resembles the motion of the wings of a windmill until the placenta can be safely delivered.